GuimarãesL, CaixetaA. Brazil: Two Realities for the Treatment of One Disease. Arq. Bras. Cardiol. 2019;112(5):571-2.
Guimarães,Leonardo; Caixeta,Adriano. Brazil: Two Realities for the Treatment of One Disease. Arq. Bras. Cardiol., v. 112, n. 5, p. 571-572, May. 2019.
Guimarães,L., & Caixeta,A. (2019). Brazil: Two Realities for the Treatment of One Disease. Arq. Bras. Cardiol.,112(5), 571-572.
Guimarães,Leonardo and Caixeta,Adriano. Brazil: Two Realities for the Treatment of One Disease. Arq. Bras. Cardiol. [online]. 2019, vol. 112, n. 5, [cited 2025-09-07], pp.571-572. Available from: <https://abccardiol.org/en/short-editorial/brazil-two-realities-for-the-treatment-of-one-disease/>. ISSN 0066-782X.
Figure 1
Dyslipidemia as a central element in atherosclerotic cardiovascular disease. ASCVD: atherosclerotic cardiovascular disease; LDL-C: low-density lipoprotein cholesterol. Limitations of statin-based therapy (non-exhaustive) include suboptimal LDL-C goal attainment, statin-associated adverse effects that may affect adherence, and potential drug interactions. Residual risk reflects the involvement of multiple underlying pathways.
